Anticancer and Tubulin Polymerisation Inhibition Activity of Benzylidene Indanones and Process of Preparing the Same
申请人:Council of Scientific and Industrial Research
公开号:US20130079396A1
公开(公告)日:2013-03-28
The present invention relates to benzylidene indanones of general formula 1. The compounds exhibited tubulin polymerisation inhibition. A series of compounds 2-benzylidene 3-(3,4,5-trimethoxyphenyl) indanones having general formulae
1
were synthesized from gallic acid through a chemical process. 2-(3,4-Methylenedioxybenzylidine), 3-(3,4,5-trimethoxyphenyl), 4,5,6-trimethoxyindanone (8), a representative compound of this series possessing the molecular formulae C
29
H
28
O
9
, was synthesized from gallic acid and exhibits potent anticancer activity. Compound 8 was evaluated for acute oral activity in Swiss albino mice and found to be safe up to 300 mg/kg body weight. The anticancer activity of the compounds has been determined, in order to obtain new potent and cost effective molecules using an in vitro cytotoxicity assay.
本发明涉及一般式1的苯甲基亚甲基吲哚酮。这些化合物表现出微管聚合抑制作用。通过化学过程从没食子酸合成了一系列一般式1的2-苯甲基亚甲基3-(3,4,5-三甲氧基苯基)吲哚酮。这个系列的代表化合物2-(3,4-亚甲二氧基苯甲亚甲基)、3-(3,4,5-三甲氧基苯基)、4,5,6-三甲氧基吲哚酮(8),其分子式为C29H28O9,由没食子酸合成,表现出强大的抗癌活性。化合物8在瑞士白化小鼠中进行急性口服活性评估,发现在体重为300毫克/千克时是安全的。通过体外细胞毒性测定,已确定这些化合物的抗癌活性,以获得新的有效且成本效益高的分子。